Concentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa: An In Vivo Pharmacokinetic/Pharmacodynamic Study

The bacterium Pseudomonas aeruginosa is known to be associated with nosocomial infections around the world. Pazufloxacin, a potent DNA gyrase inhibitor, is known to be an effective drug candidate. However, it has not been clarified whether the pharmacokinetic (PK)/pharmacodynamic (PD) of pazufloxaci...

Descripción completa

Detalles Bibliográficos
Autores principales: Umezaki, Yasuhiro, Matsumoto, Kazuaki, Ikawa, Kazuro, Yokoyama, Yuta, Enoki, Yuki, Shigemi, Akari, Watanabe, Erika, Nakamura, Koyo, Ueno, Keiichiro, Terazono, Hideyuki, Morikawa, Norifumi, Takeda, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312304/
https://www.ncbi.nlm.nih.gov/pubmed/35884236
http://dx.doi.org/10.3390/antibiotics11070982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312304/
https://www.ncbi.nlm.nih.gov/pubmed/35884236
http://dx.doi.org/10.3390/antibiotics11070982

Ejemplares similares